Acorah Software Products - Accounts Production16.0.110truetrue28 February 20231 March 2022falsetrueNo description of principal activity1 March 202328 February 202428 February 2024OC352428iso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pureOC3524282023-02-28OC3524282024-02-28OC3524282023-03-012024-02-28OC352428frs-bus:LimitedLiabilityPartnershipLLP2023-03-012024-02-28OC352428frs-bus:FilletedAccounts2023-03-012024-02-28OC352428frs-bus:Micro-entities2023-03-012024-02-28OC352428frs-bus:EntityHasNeverTraded2023-03-012024-02-28OC352428frs-bus:AuditExempt-NoAccountantsReport2023-03-012024-02-28OC352428frs-bus:PartnerLLP12023-03-012024-02-28OC3524282022-02-28OC3524282023-02-28
Registered number: OC352428
November Charlie Research LLP
Unaudited Financial Statements
For The Year Ended 28 February 2024
Xeinadin South Wales & West Limited
November Charlie Research LLP
Balance Sheet
As At 28 February 2024
Balance Sheet
Registered number: OC352428
2024
2023
£
£
TOTAL ASSETS LESS CURRENT LIABILITIES
-
-
NET ASSETS ATTRIBUTABLE TO MEMBERS
-
-
REPRESENTED BY:
Loan and other debts due to members within one year
-
-
TOTAL MEMBERS' INTERESTS
-
-
Notes
1.General Information
November Charlie Research LLP is a limited liability partnership, incorporated in England & Wales, registered number OC352428. The Registered Office is Celtic House, Caxton Place, Pentwyn, Cardiff, South Glamorgan, CF23 8HA.
For the year ending 28 February 2024 the LLP was entitled to exemption from audit under section 480 of the Companies Act 2006 (as applied by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008) relating to dormant LLPs.
The members acknowledge their responsibilities for complying with the requirements of the Act (as applied to LLPs) with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime.